Investigation of Copy Number Variations and Genetic Variants in POI
Recruiting
Observational Study
Primary Ovarian Insufficiency
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 15 – 38
- Sex
- Female
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Ospedale Policlinico San Martino · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Primary ovarian insufficiency (POI), also known as premature ovarian failure, is an ovarian defect characterized by the premature (before the age of 40 years) depletion of ovarian follicles. POI affects about 1% of women, reaching 30% in some familial cases.
This heterogeneous disorder is characterized by progressive cessation of the ovarian function with temporary or intermittent amenorrhea asso…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* age at diagnosis \<38 years;
* a normal 46,XX karyotype (no FRM1 premutation);
* at least one marker of ovarian reserve not age-appropriate:
* baseline FSH levels \> cut-off \[1\] and/or
* age-specific AMH \< cut-off \[2\] and/or
* AFC \< 5; and/or
* cancellation of a P…
Contacts